Observational studyBMC women's health2026
Factors affecting health-related quality of life in cervical cancer survivors: a multicenter cross-sectional study in Korea.
Observational study in BMC women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
Abstract
backgroundCervical cancer is the fourth most common malignancy among women worldwide. As survival rates continue to improve with advances in early detection and treatment, cervical cancer is increasingly recognized as a chronic condition, making the management of long-term health-related quality of life (HRQoL) increasingly critical. This study aimed to describe the health-related quality of life of Korean cervical cancer survivors using the EuroQol five-dimensional five-level (EQ-5D-5 L) index and identify sociodemographic, clinical, and symptom-related factors that significantly influence their health-related quality of life.
methodsA multicenter survey of 230 Korean patients was conducted using convenience sampling between August 2023 and February 2024. Health-related quality of life was assessed using the EQ-5D-5 L, with scores ranging from 0 (equivalent to death) to 1 (full health). Wilcoxon rank-sum and Kruskal-Wallis tests were used to compare health-related quality of life distributions, and multiple linear regression analyses were used to identify the influencing factors.
resultsA total of 230 female cervical cancer survivors were enrolled (mean age: 52.6 ± 11.7 years). Most were married (63.9%) and lived with two or more household members (81.7%). The mean EQ-5D-5 L index score was 0.85 ± 0.14. Significant differences in HRQoL were observed across marital status, household size, income level, hypertension, disease status, International Federation of Gynecology and Obstetrics (FIGO) stage, time since last treatment, and dyspnea severity (all p-values < 0.05). Multiple linear regression (R² = 0.689) identified advanced FIGO stage II (β = − 0.17, p < 0.001) and IV (β = − 0.12, p = 0.024), chemotherapy alone within one year (β = − 0.22, p = 0.026), and dyspnea (β = − 0.05, p = 0.037) as independent negative predictors of HRQoL, whereas living with two or more household members was independently associated with better HRQoL (β = 0.10, p = 0.045).
conclusionOur results demonstrate that cervical cancer is significantly associated with a lower health-related quality of life than in the general population, with advanced cancer stage, chemotherapy, and dyspnea symptoms being the major independent negative predictors. Sociodemographic factors, particularly household composition, also play a significant role in patients’ well-being. These findings highlight the importance of incorporating patient-centered supportive care into cancer management, especially for those with advanced disease or those undergoing chemotherapy, to mitigate the symptom burden and improve the overall quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.